Progressive Multiple Sclerosis Active Not Recruiting Phase 1 Trials for Loratadine (DB00455)

Back to Progressive Multiple Sclerosis

Also known as: Progressive multiple sclerosis

IndicationStatusPhase
DBCOND0051688 (Progressive Multiple Sclerosis)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02583594A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple SclerosisTreatment